Therapeutically Growth in Oligodendroglia Fate Induction via Trans Differentiation of Stem Cells for Neurodegenerative Therapy
Received Date: May 01, 2023 / Published Date: May 29, 2023
Abstract
The benefits of stem cell therapy and research are undeniable given how frequently they are used to treat demyelinating illnesses and neurodegenerative diseases. Prior to transplantation or disease modelling research, stem cells are induced into several cell lineages, both adult and progenitor - belonging to each germ layer - in cell replacement treatment. The nervous system contains a large number of glial cells, including oligodendrocytes, which can remyelinate axons that have lost or damaged myelin sheaths as well as myelinate newly formed neurons. Yet, myelin breakdown and regeneration are drastically outpaced by demyelinating illnesses. Mesenchymal stem cells (MSCs) have been stimulated to transdifferentiate in order to make up for this loss, examine the abnormalities in remyelination pathways, and accelerate full recovery in such individuals.
Citation: Armour D (2023) Therapeutically Growth in Oligodendroglia FateInduction via Trans Differentiation of Stem Cells for Neurodegenerative Therapy.Arch Sci 7: 154. Doi: 10.4172/science.1000154
Copyright: © 2023 Armour D. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
黑料网 Journals
Article Tools
Article Usage
- Total views: 659
- [From(publication date): 0-2023 - Mar 10, 2025]
- Breakdown by view type
- HTML page views: 569
- PDF downloads: 90
